Affiliated with a Castle Connolly Top Hospital
Who is Dr. Blayney, Medical Oncologist in Stanford, CA?
Dr. Douglas Blayney, MD is a Medical Oncologist, who primarily practices in Stanford, CA with 2 additional practice locations. He is board certified by the American Board of Internal Medicine. Dr. Blayney completed his residency at Univ Ca San Diego Med Ctr, Internal Medicine. Dr. Blayney is fluent in English and Spanish, and is currently seeing new patients. Dr. Blayney’s practice accepts Medicaid, Medicare, UnitedHealthcare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Blayney’s office.
Where did Dr. Blayney go to medical school and complete their residency?
Fellowship: Medicine Branch, National Cancer Institute, Bethesda, Maryland
Residency: Univ Ca San Diego Med Ctr, Internal Medicine | UCSD School of Medicine
Medical School: University of Ca, San Diego, Sch of Med, La Jolla Ca
Is Dr. Blayney board certified in Medical Oncologist?
Yes, Dr. Douglas Blayney, MD is board certified by the American Board of Internal Medicine , American Board of Internal Medicine since 1983, American Board of Internal Medicine since 1980
What languages does Dr. Blayney speak?
Dr. Blayney and their clinical team can communicate with patients in the following languages:
English
Spanish
What conditions does Dr. Blayney treat?
As a Medical Oncologist, Dr. Blayney diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Blayney. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly.
Also known as:
- Breast Cancer
- Right Female Nipple and Areola Breast Cancer
- Left Female Nipple and Areola Breast Cancer
- Mammary cancer
- Breast carcinoma
- Breast tumor
- Female Breast Cancer
- Malignant Breast Tumor
- Breast Carcinoma
- Cancer of right female nipple
- Right female areola tumor
- Malignant growth on right female nipple
- Cancer of left female nipple
- Left female areola tumor
- Malignant growth on left female nipple
ICD-10 Codes:
- C50911: Malignant neoplasm of unspecified site of right female breast
- C50912: Malignant neoplasm of unspecified site of left female breast
- C50919: Malignant neoplasm of unspecified site of unspecified female breast
- C50011: Malignant neoplasm of nipple and areola, right female breast
- C50012: Malignant neoplasm of nipple and areola, left female breast
Also known as:
- Personal History of Breast Cancer
- Breast Cancer
- Past breast cancer
- Previous mammary malignancy
- History of breast tumor
ICD-10 Codes:
- Z853: Personal history of malignant neoplasm of breast
Also known as:
- Secondary Bone Cancer
- Bone Cancer
- Metastatic bone cancer
- Cancer spread to bone
- Bone metastases
ICD-10 Codes:
- C7951: Secondary malignant neoplasm of bone
Also known as:
- Mammogram for Breast Cancer Screening
- Health Screening
- Mammography
- Breast Cancer Screening (PDQ®)
- Mammograms
- Breast X-ray
- Breast Cancer Check
ICD-10 Codes:
- Z1231: Encounter for screening mammogram for malignant neoplasm of breast
Which procedures does Dr. Blayney perform as a Medical Oncologist?
As a Medical Oncologist, procedures performed by a Dr. Douglas Blayney may include:
- 3D Conformal Radiotherapy
- Adaptive Radiation Therapy (ART)
- Adrenalectomy
- Blood Thinning Therapy / Anticoagulation
- Blood Transfusion Consultation
- Blood Transfusion Follow Up
- Bone Excision
- Bone Grafting
For detailed information, please contact Dr. Blayney's office.
Does Dr. Blayney accept my insurance?
Dr. Blayney accepts most major insurance plans. Important: Please call our office at before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Blayney accept in Stanford, CA?
Dr. Blayney in Stanford, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
Advantage
All Other Third Party
Medicaid
Medicare
UnitedHealthcare
View All Insurances
Where is Dr. Blayney's office located?
Recognitions
Publications
Transforming cancer care: are transdiscipliry approaches using design-thinking, engineering
Jourl of oncology practice / American Society of Clinical Oncology, 2014
American society of clinical oncology 2013 top five list in oncology.
Jourl of clinical oncology, 2013
ASCO's Quality Care Symposium (November 1-2, 2013) Abstracts
JOURL OF CLINICAL ONCOLOGY, 2013
Computerized prescriber order entry implementation in a physician assistant-maged hematology
Jourl of oncology practice / American Society of Clinical Oncology, 2013
Measuring the Improving Quality of Outpatient Care in Medical Oncology Practices in the United
JOURL OF CLINICAL ONCOLOGY, 2013
Tumor Boards (Team Huddles) Aren't Enough to Reach the Goal
JNCI-JOURL OF THE TIOL CANCER INSTITUTE, 2013
Adoption of Gene Expression Profile Testing
JOURL OF CLINICAL ONCOLOGY, 2012
American Society of Clinical Oncology Identifies Five Key Opportunities to Improve Care
JOURL OF CLINICAL ONCOLOGY, 2012
Enhancing Quality Through Innovation
JOURL OF CLINICAL ONCOLOGY, 2010
Implementation of the Quality Oncology Practice Initiative at a University Comprehensive Cancer
JOURL OF CLINICAL ONCOLOGY, 2009
Myeloid Growth Factors
JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORK, 2013
Measuring and improving quality of care in an academic medical center.
Jourl of oncology practice / American Society of Clinical Oncology, 2013
Comparative outcome of initial therapy for younger patients with mantle cell lymphoma
BLOOD, 2012
The impact of obesity on receipt of adjuvant chemotherapy for breast cancer
BREAST CANCER RESEARCH AND TREATMENT, 2011
Commentary: six years of trends in oncology practice data.
Jourl of oncology practice / American Society of Clinical Oncology, 2011
Myeloid Growth Factors
JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORK, 2011
Institutiol Variation in the Surgical Treatment of Breast Cancer A Study of the NCCN
ANLS OF SURGERY, 2011
Continued Use of Trastuzumab Beyond Disease Progression in the tiol Comprehensive Cancer Network
ONCOLOGIST, 2011
Challenges to tiol Cancer Institute-Supported Cooperative Group Clinical Trial Participation
Jourl of oncology practice / American Society of Clinical Oncology, 2010
Partnering with payers for success
Jourl of oncology practice / American Society of Clinical Oncology, 2009
Lymphoma After Solid Organ Transplantation: Risk, Response to Therapy
JOURL OF CLINICAL ONCOLOGY, 2009
Chemotherapy Use for Hormone Receptor-Positive, Lymph Node-Negative Breast Cancer
JOURL OF CLINICAL ONCOLOGY, 2008
The registry case finding engine
JOURL OF THE AMERICAN COLLEGE OF SURGEONS, 2007
Defining Quality: QOPI Is a Start.
Jourl of oncology practice / American Society of Clinical Oncology, 2006
Dose-intense chemotherapy every 2 weeks with dose-intense cyclophosphamide, doxorubicin
JOURL OF CLINICAL ONCOLOGY, 2003
DECREASING RISK OF LEUKEMIA WITH PROLONGED FOLLOW
NEW ENGLAND JOURL OF MEDICINE, 1987
THE HUMAN T-CELL LEUKEMIA-LYMPHOMA VIRUS IN THE SOUTHEASTERN UNITED-STATES
JAMA-JOURL OF THE AMERICAN MEDICAL ASSOCIATION, 1983
THE HUMAN T-CELL LEUKEMIA LYMPHOMA VIRUS, LYMPHOMA, LYTIC BONE-LESIONS, AND HYPERCALCEMIA
ANLS OF INTERL MEDICINE, 1983
Transforming cancer care: are transdisciplinary approaches using design-thinking, engineering
Journal of oncology practice / American Society of Clinical Oncology, 2014
Breast cancer treatment across health care systems
Cancer, 2014
American society of clinical oncology 2013 top five list in oncology.
Journal of clinical oncology, 2013
ASCO's Quality Care Symposium (November 1-2, 2013) Abstracts
JOURNAL OF CLINICAL ONCOLOGY, 2013
Computerized prescriber order entry implementation in a physician assistant-managed hematology
Journal of oncology practice / American Society of Clinical Oncology, 2013
Measuring the Improving Quality of Outpatient Care in Medical Oncology Practices in the United
JOURNAL OF CLINICAL ONCOLOGY, 2013
Tumor Boards (Team Huddles) Aren't Enough to Reach the Goal
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013
Adoption of Gene Expression Profile Testing
JOURNAL OF CLINICAL ONCOLOGY, 2012
American Society of Clinical Oncology Identifies Five Key Opportunities to Improve Care
JOURNAL OF CLINICAL ONCOLOGY, 2012
Michigan Oncology Practices Showed Varying Adherence Rates To Practice Guidelines
HEALTH AFFAIRS, 2012
Enhancing Quality Through Innovation
JOURNAL OF CLINICAL ONCOLOGY, 2010
Implementation of the Quality Oncology Practice Initiative at a University Comprehensive Cancer
JOURNAL OF CLINICAL ONCOLOGY, 2009
Breast Cancer Treatment Across Health Care Systems
CANCER, 2014
Myeloid Growth Factors
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2013
Measuring and improving quality of care in an academic medical center.
Journal of oncology practice / American Society of Clinical Oncology, 2013
Time to diagnosis and breast cancer stage by race/ethnicity
BREAST CANCER RESEARCH AND TREATMENT, 2012
Clinicopathologic Features, Patterns of Recurrence
CANCER, 2012
The anemia impact measure (AIM)
QUALITY OF LIFE RESEARCH, 2012
The Effect of Age on Delay in Diagnosis and Stage of Breast Cancer
ONCOLOGIST, 2012
Comparative outcome of initial therapy for younger patients with mantle cell lymphoma
BLOOD, 2012
The impact of obesity on receipt of adjuvant chemotherapy for breast cancer
BREAST CANCER RESEARCH AND TREATMENT, 2011
Commentary: six years of trends in oncology practice data.
Journal of oncology practice / American Society of Clinical Oncology, 2011
Myeloid Growth Factors
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2011
Institutional Variation in the Surgical Treatment of Breast Cancer A Study of the NCCN
ANNALS OF SURGERY, 2011
Continued Use of Trastuzumab Beyond Disease Progression
ONCOLOGIST, 2011
Expansion of cancer care and control in countries of low and middle income: a call to action
LANCET, 2010
Challenges to National Cancer Institute-Supported Cooperative Group Clinical Trial Participation
Journal of oncology practice / American Society of Clinical Oncology, 2010
Partnering with payers for success
Journal of oncology practice / American Society of Clinical Oncology, 2009
Lymphoma After Solid Organ Transplantation: Risk, Response to Therapy
JOURNAL OF CLINICAL ONCOLOGY, 2009
Chemotherapy Use for Hormone Receptor-Positive, Lymph Node-Negative Breast Cancer
JOURNAL OF CLINICAL ONCOLOGY, 2008
The registry case finding engine
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2007
Defining Quality: QOPI Is a Start.
Journal of oncology practice / American Society of Clinical Oncology, 2006
Dose-intense chemotherapy every 2 weeks with dose-intense cyclophosphamide, doxorubicin
JOURNAL OF CLINICAL ONCOLOGY, 2003
DECREASING RISK OF LEUKEMIA WITH PROLONGED FOLLOW
NEW ENGLAND JOURNAL OF MEDICINE, 1987
THE HUMAN T-CELL LEUKEMIA-LYMPHOMA VIRUS IN THE SOUTHEASTERN UNITED-STATES
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1983
THE HUMAN T-CELL LEUKEMIA LYMPHOMA VIRUS, LYMPHOMA, LYTIC BONE-LESIONS, AND HYPERCALCEMIA
ANNALS OF INTERNAL MEDICINE, 1983
THE HUMAN T-CELL LEUKEMIA LYMPHOMA VIRUS ASSOCIATED WITH AMERICAN ADULT T-CELL LEUKEMIA LYMPHOMA
BLOOD, 1983
What is Dr. Blayney's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Blayney's National Provider Identifier (NPI) number is 1811073877.
What common questions do patients ask about Dr. Blayney?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Blayney
What is Dr. Douglas Blayney's specialty?
Dr. Blayney is a Medical Oncologist near Stanford, CA. An internist specializing in the diagnosis and treatment of various cancers and both benign and malignant tumors. This specialist determines and administers therapy for malignancies and collaborates with surgeons and radiation oncologists on additional cancer treatment options. Contact Dr. Blayney to book an appointment today.
Is this Dr. Douglas Blayney affiliated with a ranked Castle Connolly Top Hospital?
Yes, Dr. Blayney is affiliated with Stanford Health Care - Stanford Hospital which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals
Where can I learn more about Medical Oncologist?
Explore Medical Oncologist with insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.
Is Douglas Blayney accepting new patients in Stanford, CA?
Yes, Dr. Douglas Blayney is accepting new patients at this time.
Does Dr. Douglas Blayney offer online booking?
Please contact Dr. Blayney's office for information about online booking, telehealth, or to schedule an appointment.
How can I make an appointment with Douglas Blayney?
Please contact Dr. Blayney's office for information regarding telehealth appointment availability or for scheduling assistance.
Which board certifications does Dr. Douglas Blayney have?
Dr. Douglas Blayney is certified by the American Board of Internal Medicine.
Other Medical Oncologist Near Stanford, CA
Hematologist
Accepting patientsMedical Oncologist
Accepting patientsMedical Oncologist
Accepting patients